Treatment of Metastatic Triple-Negative Breast Cancer
The Pharma Data
MARCH 25, 2021
Food and Drug Administration (FDA) to treat adult patients with metastatic TNBC who have received at least two prior therapies for metastatic disease. Canada, Switzerland and Australia, as well as in Singapore through our partner Everest Medicines. Premedicate with a 2- or 3-drug combination regimen (e.g., Gilead Sciences, Inc.
Let's personalize your content